UnknownNot Applicable

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

South Korea228 participantsStarted 2016-06

Plain-language summary

The aim of this prospective study is to reveal the natural history of symptomatic hemorrhage in adult patients with cerebral cavernous malformation with the goal of informing the treatment plan.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with newly diagnosed cerebral cavernous malformation who agreed to participate. * 18 years old or more Exclusion Criteria: * Patients who underwent treatment(surgery or radiosurgery) for cavernous malformation * Patients who are accompanied by other serious medical problems

What they're measuring

Symptomatic hemorrhage

Timeframe: 5 year

Trial details

NCT IDNCT02946866

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12

View on ClinicalTrials.gov More Cerebral Cavernous Malformation trials